ZURICH (Reuters) – Roche is launching a SARS-CoV-2 variant test to help monitor emerging coronavirus mutations, the Swiss pharmaceuticals group said on Tuesday. The test here runs on widely used high-throughput systems and is for research purposes only.
“Periodic assessments against emerging variants have shown that Roche’s current diagnostic tests for detecting active SARS-CoV-2 infections remain accurate and effective,” it said.
Novo Nordisk contracts Aspen to produce insulin for Africa | Reuters Novo Nordisk (NOVOb.CO) has contracted...
Germany on Monday launched its autumn vaccination campaign to prevent respiratory infection, promoting an updated COVID-19...
Wendy Nelson stands at Uhuru Peak of Mt. Kilimanjaro, the highest point on the continent of...
Wendy Nelson watched her mother slowly die of Alzheimer’s disease, unable to move or swallow at...
Why Europe’s drug shortages may get worse | Reuter Most European countries reporting shortages of antibiotics...
